Authors: Ajani, JA Baker, J Pisters, PW Ho, LN Feig, B Mansfield, PF

Citation: Ja. Ajani et al., Irinotecan plus cisplatin in advanced gastric or gastroesophageal junctioncarcinoma, ONCOLOGY-NY, 15(3), 2001, pp. 52-54

Authors: Xiong, SB Grijalva, R Zhang, LL Nguyen, NT Pisters, PW Pollock, RE Yu, DH

Citation: Sb. Xiong et al., Up regulation of vascular endothelial growth factor in breast cancer cellsby the heregulin-beta 1-activated p38 signaling pathway enhances endothelial cell migration, CANCER RES, 61(4), 2001, pp. 1727-1732

Authors: Ajani, JA Komaki, R Putnam, JB Walsh, G Nesbitt, J Pisters, PW Lynch, PM Vaporciyan, A Smythe, R Lahoti, S Raijman, I Swisher, S Martin, FD Roth, JA

Citation: Ja. Ajani et al., A three-step strategy of induction chemotherapy then chemoradiation followed by surgery in patients with potentially resectable carcinoma of the esophagus or gastroesophageal junction, CANCER, 92(2), 2001, pp. 279-286

Authors: Ajani, JA Fairweather, J Pisters, PW Charnsangavej, C

Citation: Ja. Ajani et al., Irinotecan and cisplatin in advanced gastric or gastroesophageal junction carcinoma, ONCOLOGY-NY, 14(12), 2000, pp. 19-21

Authors: Ajani, JA Mansfield, PF Lynch, PM Pisters, PW Feig, B Dumas, P Evans, DB Raijman, I Hargraves, K Curley, S Ota, DM

Citation: Ja. Ajani et al., Enhanced staging and all chemotherapy preoperatively in patients with potentially resectable gastric carcinoma, J CL ONCOL, 17(8), 1999, pp. 2403-2411